Netherlands (Kingdom of the) vs Solomon Islands: Proportion of the target population who received a 3rd dose of
Netherlands (Kingdom of the)
88.0%
in 2024
Solomon Islands
88.0%
in 2024
Netherlands (Kingdom of the) rank
80th
Solomon Islands rank
80th
Proportion of the target population who received a 3rd dose of over time
- Netherlands (Kingdom of the)
- Solomon Islands
How they compare
Netherlands (Kingdom of the) currently reports 88.0% against 88.0% in Solomon Islands, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Netherlands (Kingdom of the) ahead.
Netherlands (Kingdom of the) ranks 80th and Solomon Islands ranks 80th of 157 countries.
Netherlands (Kingdom of the) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands (Kingdom of the) | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.4% | 77.6% | 15.8% | Netherlands (Kingdom of the) |
| 2020s | 90.4% | 87.4% | 3.0% | Netherlands (Kingdom of the) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Netherlands (Kingdom of the) or Solomon Islands?
- Netherlands (Kingdom of the), at 88.0% against 88.0% in Solomon Islands as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Netherlands (Kingdom of the) and Solomon Islands?
- 0.0%, with Netherlands (Kingdom of the) ahead.
- How many years of comparable data are there for Netherlands (Kingdom of the) and Solomon Islands?
- 10 years are reported by both, from 2015 to 2024.
- How do Netherlands (Kingdom of the) and Solomon Islands rank globally for proportion of the target population who received a 3rd dose of?
- Netherlands (Kingdom of the) ranks 80th and Solomon Islands ranks 80th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.